Key Insights

Highlights

Success Rate

81% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

10.4%

5 terminated out of 48 trials

Success Rate

80.8%

-5.7% vs benchmark

Late-Stage Pipeline

27%

13 trials in Phase 3/4

Results Transparency

29%

6 of 21 completed with results

Key Signals

6 with results81% success

Data Visualizations

Phase Distribution

36Total
Not Applicable (7)
Early P 1 (1)
P 1 (6)
P 2 (9)
P 3 (7)
P 4 (6)

Trial Status

Completed21
Unknown12
Recruiting8
Terminated5
Active Not Recruiting1
Withdrawn1

Trial Success Rate

80.8%

Benchmark: 86.5%

Based on 21 completed trials

Clinical Trials (48)

Showing 20 of 20 trials
NCT06830798Phase 3RecruitingPrimary

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

NCT04005469Phase 1Recruiting

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

NCT05907096Phase 2Active Not RecruitingPrimary

ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function

NCT07020832Phase 3RecruitingPrimary

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation

NCT07275632Phase 1RecruitingPrimary

The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients

NCT02727296Phase 4CompletedPrimary

Volatile Anesthetic Protection Of Renal Transplants 2

NCT06855758Not ApplicableRecruiting

Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation

NCT03829488Phase 3Completed

Better Evidence for Selecting Transplant Fluids

NCT06641622Completed

Study of the Correlation Between Donor CIRBP and Transplanted Kidney Function

NCT05513807Phase 3CompletedPrimary

Graft Acute Kidney Injury: Vitamin B3 to Facilitate Renal Recovery In the Early Life of a Transplant

NCT05430620Phase 3RecruitingPrimary

Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys

NCT06367205Not ApplicableRecruitingPrimary

Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations

NCT03071536Not ApplicableRecruiting

Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation

NCT03864926Phase 4CompletedPrimary

Envarsus in Delayed Graft Function (E-DGF)

NCT05166460Not ApplicableUnknown

Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation

NCT02525510Not ApplicableCompleted

Deceased Organ Donor Interventions to Protect Kidney Graft Function

NCT00931255Phase 4Terminated

Tacrolimus to Sirolimus Conversion for Delayed Graft Function

NCT02134288Early Phase 1TerminatedPrimary

Belatacept for Renal Transplant Recipients With Delayed Graft Function

NCT02474667Phase 3UnknownPrimary

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

NCT03773211Phase 1CompletedPrimary

Renaparin® in Kidney Transplantation

Scroll to load more

Research Network

Activity Timeline